Company news
Neuronetics, Inc. (NASDAQ:STIM) news
Every Neuronetics, Inc. press release and news update in one place — announcements, filings coverage, and company updates for investors.
Press releases & updates
NeuroStar Advances Practice Innovation with First-Ever TMS Integration with an EHR/EMR System
September 8, 2026
Neuronetics Reports Second Quarter 2026 Financial and Operating Results
August 11, 2026
Neuronetics and Jorey Chernett Announce Shared Vision
August 3, 2026
Greenbrook Opens National Center of Excellence for Advanced Interventional Psychiatry in Rockville, Maryland
July 28, 2026
Neuronetics to Report Second Quarter 2026 Financial and Operating Results and Host Conference Call
July 28, 2026
Neuronetics Appoints Nir Naor Chief Financial Officer; Announces Additional Management Changes
July 20, 2026
Neuronetics to Participate in a Panel Discussion at B. Riley Securities' Mind, Muscle & Vision Summit on July 16, 2026
July 6, 2026
Neuronetics Appoints Robert Greene as Senior Vice President Sales
June 2, 2026
Neuronetics Highlights Continued Advancements in TMS Research at CTMSS 2026
June 2, 2026
Neuronetics and ANT Neuro Announce Strategic Collaboration to Integrate Neuronavigation with NeuroStar TMS Treatment
May 14, 2026
Neuronetics Reports First Quarter 2026 Financial and Operating Results
May 5, 2026
Neuronetics to Report First Quarter 2026 Financial and Operating Results and Host Conference Call
April 21, 2026
Neuronetics Comments on Letter from Pointillist Family Office
April 7, 2026
Neuronetics Announces Chief Financial Officer Transition
April 6, 2026
Neuronetics Reports Fourth Quarter and Full Year 2025 Financial and Operating Results
March 17, 2026
Neuronetics Appoints Dan Reuvers as President and Chief Executive Officer
March 17, 2026
Neuronetics to Report Fourth Quarter 2025 Financial and Operating Results and Host Conference Call
March 3, 2026
Neuronetics Announces Selected Preliminary Unaudited Fourth Quarter and Full Year 2025 Financial Results
February 10, 2026
Neuronetics to Participate at the Piper Sandler 37th Annual Healthcare Conference
November 20, 2025
TRICARE West Expands NeuroStar® TMS Coverage to Include Adolescents Aged 15+ Struggling with Depression
November 12, 2025
Neuronetics Reports Third Quarter 2025 Financial and Operating Results and Announces CEO Transition Plan
November 4, 2025
Neuronetics Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
October 31, 2025
Neuronetics Announces Three-Year Exclusive Partnership with Elite DNA Behavioral Health to Expand NeuroStar Access and Operational Excell...
October 30, 2025
Neuronetics to Report Third Quarter 2025 Financial and Operating Results and Host Conference Call
October 21, 2025
New York State Medicaid Expands Coverage for TMS Therapy, Including NeuroStar® Advanced Therapy, to Treat Major Depressive Disorder (MDD)
September 17, 2025
Neuronetics Reports Second Quarter 2025 Financial and Operating Results
August 5, 2025
Neuronetics to Present at the Canaccord Genuity 45th Annual Growth Conference
August 4, 2025
NeuroStar Announces New Publication in JAACAP Open Highlighting Treatment Efficacy in Depressed Adolescents
July 30, 2025
Neuronetics to Report Second Quarter 2025 Financial and Operating Results and Host Conference Call
July 22, 2025
Neuronetics Appoints New Chief Financial Officer
July 15, 2025
Neuronetics Announces Clinical Presence at the 2025 Clinical TMS Society Annual Meeting and Progress in Greenbrook’s Personalized Care Tr...
June 10, 2025
Neuronetics Set to Join Russell 2000® and Russell 3000® Indexes
June 2, 2025
Neuronetics Launches First Inaugural National TMS Therapy Awareness Day During Mental Health Awareness Month
May 14, 2025
Neuronetics Reports First Quarter 2025 Financial and Operating Results
May 6, 2025
Neuronetics to Report First Quarter 2025 Financial and Operating Results and Host Conference Call
April 22, 2025
Evernorth Health Services, a Cigna Company, Expands NeuroStar® TMS Coverage for Adolescents Struggling with Depression
March 31, 2025
Neuronetics Reports Updated Fourth Quarter and Full Year 2024 Financial and Operating Results
March 27, 2025
Neuronetics Reports Fourth Quarter and Full Year 2024 Financial and Operating Results
March 4, 2025
Neuronetics to Report Fourth Quarter 2024 Financial and Operating Results and Host Conference Call
February 21, 2025
Neuronetics Announces Pricing of $18 Million Underwritten Public Offering of Common Stock
February 7, 2025
Neuronetics Announces Launch of Underwritten Public Offering of Common Stock
February 6, 2025
NeuroStar Unveils Two Significant Publications on TMS Therapy for Depression
January 29, 2025
Neuronetics Provides Business Update and Issues 2025 Guidance
January 13, 2025
Neuronetics and Greenbrook TMS Announce Closing of Transaction
December 10, 2024
Neuronetics to Present at the Piper Sandler 36th Annual Healthcare Conference
November 20, 2024
Neuronetics Reports Record Third Quarter 2024 Financial and Operating Results
November 12, 2024
Neuronetics to Report Third Quarter 2024 Financial and Operating Results and Host Conference Call
October 29, 2024
NeuroStar® Oral Presentation at AACAP 2024 Highlights Largest Study Evaluating TMS Efficacy in Adolescents with Depression
October 14, 2024
Neuronetics and Greenbrook TMS Announce Receipt of Interim Order in Respect of Proposed Arrangement and Provide Details of Shareholder Me...
October 4, 2024
Expanded Health Policies Enhance TMS Therapy Access for Adolescents and Adults
September 19, 2024